EGFR and Barrett esophagus: Furthermore, EGF and EGFR mRNA expression did not vary significantly between esophageal tissues with or without visible pathological changes or among the different diagnoses (p > 0.05), suggesting that these biomarkers are not determinants of the risk or progression of BE and EAC [114].